Abstract
Shigatoxin Escherichia coli-related hemolytic uremic syndrome (eHUS) is a severe thrombotic microangiopathy (TMA) burdened by life-threatening complications and long-term sequelae. Since hemoconcentration is associated with worse outcome, we tried to develop a reliable and easy-to-calculate index for predicting complications and sequelae based on hemoglobin (Hb) at presentation. The first laboratory examinations with signs of TMA in eHUS patients were analyzed in relation to the outcomes with the receiver operating characteristic curves and their areas under the curve (AUC) for Hb and creatinine (sCr). A total of 197 eHUS patients were identified of whom 24% did not have anemia at presentation. Hb level was the best predictor of a poor outcome (AUC 0.67) but the combination of Hb with sCr, in the formula [(Hb in g/dL + (sCr in mg/dL × 2)], showed an even better AUC of 0.75. The described scoring system was also strongly associated and predictive of all complications and health care needs (8% of patients with scoring > 13 died or entered a permanent vegetative state compared with 0% of those with ≤ 13).
Conclusion: The presented score is a simple and early predictor of both short- and long-term outcomes and identifies patients who should undergo rapid volume expansion to counteract hemoconcentration, the spreading of microvascular thrombosis, and the consequent increased organ damage.
What is Known: • In eHUS, hemoconcentration is associated with worse short- and long-term outcome. • A prognostic index to identify patients at higher risk for complications at presentation is not available. | |
What is New: • We developed a simple and early prognostic index for eHUS outcome with the combination of Hb and sCr at onset, in the following formula [(Hb in g/dL + (sCr in mg/dL × 2)]. • The proposed HUS Severity Score can promptly identify patients with good outcome and those with high risk of worse short- and long-term outcome. |
Similar content being viewed by others
Abbreviations
- AUC:
-
Area under the curve
- CKD:
-
Chronic kidney disease
- eGFR:
-
Estimated glomerular filtration rate
- IQR:
-
Interquartile range
- eHSS:
-
eHUS Severity Score
- eHUS:
-
Shigatoxin Escherichia coli-related hemolytic uremic syndrome
- Hb:
-
Hemoglobin
- LDH:
-
Lactate dehydrogenase
- ROC:
-
Receiver operating characteristic
- RRT:
-
Renal replacement therapy
- STEC:
-
Shiga Toxin E. Coli
- sCr:
-
Serum creatinine
- TMA:
-
Thrombotic microangiopathy
References
Ardissino G, Possenti I, Tel F, Testa S, Paglialonga F (2014) Time to change the definition of hemolytic uremic syndrome. Eur J Intern Med 25:e29. https://doi.org/10.1016/j.ejim.2013.12.002
Ardissino G, Daccò V, Testa S, Civitillo CF, Tel F, Possenti I, Belingheri M, Castorina P, Bolsa-Ghiringhelli N, Tedeschi S, Paglialonga F, Salardi S, Consonni D, Zoia E, Salice P, Chidini G (2015) Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome. Pediatr Nephrol 30:345–352. https://doi.org/10.1007/s00467-014-2918-0
Ardissino G, Salardi S, Colombo E, Testa S, Borsa-Ghiringhelli N, Paglialonga F, Paracchini V, Tel F, Possenti I, Belingheri M, Civitillo CF, Sardini S, Ceruti R, Baldioli C, Tommasi P, Parola L, Russo F, Tedeschi S (2016) Epidemiology of haemolytic uremic syndrome in children. Data from the north Italian HUS network. Eur J Pediatr 175:465–473. https://doi.org/10.1007/s00431-015-2642-1
Ardissino G, Tel F, Possenti I, Testa S, Consonni D, Paglialonga F, Salardi S, Borsa-Ghiringhelli N, Salice P, Tedeschi S, Castorina P, Colombo RM, Arghittu M, Daprai L, Monzani A, Tozzoli R, Brigotti M, Torresani E (2016) Early volume expansion and outcomes of hemolytic uremic syndrome. Pediatrics 137:1–9. https://doi.org/10.1542/peds.2015-2153.
Ardissino G, Tel F, Picicco D, Dodaro A, Daprai L, Consolo S, Testa S, Paglialonga F, Consonni D, ItalKid HUS Network (2018) Comment on “blood urea nitrogen to serum creatinine ratio is an accurate predictor of outcome in diarrhea-associated hemolytic uremic syndrome” by Keenswijk et al. Eur J Pediatr 2017;176(3): 355-360. Eur J Pediatr 177:269–270. https://doi.org/10.1007/s00431-017-2989-6
Balestracci A, Martin SM, Toledo I, Alvarado C, Wainsztein RE (2012) Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome children. Pediatr Nephrol 27:1407–1410. https://doi.org/10.1007/s00467-012-2158-0
Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D, Rosas-Arellano MP, Salvadori M, Haynes RB, Clarck WF (2003) Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 290:1360–1370. https://doi.org/10.1001/jama.290.10.1360
Keenswijk W, Vanmassenhove J, Raes A, Dhont E, Vande Walle J (2017) Blood urea nitrogen to serum creatinine ratio is an accurate predictor of outcome in diarrhea-associated hemolytic uremic syndrome, a preliminary study. Eur J Pediatr 176:355–360. https://doi.org/10.1007/s00431-016-2846-z
Loos S, Ahlenstiel T, Kranz B, Staude H, Pape L, Härtel C, Vester U, Buchtala L, Benz K, Hoppe B, Beringer O, Krause M, Müller D, Pohl M, Lemke J, Hillebrand G, Kreuzer M, König J, Wigger M, Konrad M, Haffner D, Oh J, Kemper MJ (2012) An outbreak of Shiga toxin–producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis 55:753–759. https://doi.org/10.1093/cid/cis531
Mody RK, Gu W, Griffin PM, Jones TF, Rounds J, Shiferaw B, Tobin-D’Angelo M, Smith G, Spina N, Hurd S, Lathrop S, Palmer A, Boothe E, Luna-Gierke RE, Hoekstra RM (2015) Postdiarrheal hemolytic uremic syndrome in United States children: clinical spectrum and predictors of in-hospital death. J Pediatr 166:1022102–1022109. https://doi.org/10.1016/j.jpeds.2014.12.064
Oakes RS, Siegler RL, McReynolds MA, Pysher T, Pavia AT (2006) Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics 117:1656–1662. https://doi.org/10.1542/peds.2005-0785
Oakes RS, Kirkham JK, Nelson RD, Siegler RL (2008) Duration of oliguria and anuria predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome. Pediatr Nephrol 23:1303–1308. https://doi.org/10.1007/s00467-008-0799-9
Ojeda JM, Kohout I, Cuestas E (2013) Dehydration upon admission is a risk factor for incomplete recovery of renal function in children with haemolytic uremic syndrome. Nefrologia 33:372–376. https://doi.org/10.3265/Nefrologia.pre2012.Nov.11648.
Scheiring J, Andreoli SP, Zimmerhackl LB (2008) Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 23:1749–1760. https://doi.org/10.1007/s00467-008-0935-6
Siegler RL, Pavia AT, Christofferson RD, Milligan MK (1994) A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics 94:35–40
Spinale JM, Ruebner RL, Copelovitch L, Kaplan BS (2013) Long-term outcomes of Shiga toxin hemolytic uremic syndrome. Pediatr Nephrol 28:2097–2105. https://doi.org/10.1007/s00467-012-2383-6
Acknowledgements
The following members of the ItalKid-HUS Network, to whom we are particularly thankful, gave an essential contribution to the present study: P. Accorsi (Pieve di Coriano), N. Altamura (Sesto San Giovanni), S. Andreoni (Novara), C. Baldioli (Cittiglio), B. Balduzzi (Esine), A. Bonazza (Brescia), A. Bonomini (Melzo), G. Bossi (Pavia), E. Cama (Desenzano del Garda), P. Carlucci (Milano), M. Casciana (Mantova), D. Casnaghi (Rho), R. Celano (Milano), R. Ceruti (Mantova), M. Facchini (Milano), C. Giacomazzi (Aosta), V. Goj (Milano), S. Grossi (Brescia), S. Maiandi (Lodi), ML. Melzi (Monza), E. Milanesi (Cremona), A. Monzani (Novara), A. Negri (Varese), B. Osnaghi (Magenta), F. Pagani (Brescia), L. Parola (Magenta), P. Pedroni (Manerbio), A. Pellegatta (Busto Arsizio), I. Possenti (Alessandria), A. Reciputo (Cinisello Balsamo), B. Roman (Vimercate), A. Rosco (Garbagnate), F. Salvini (Milano), S. Sardini (Asola), C. Sciuto (Lecco), M. Silvestri (Verbania), P. Tommasi (Milano), and C. Zambetti (Lodi). We would like to thank PROGETTO ALICE–ASSOCIAZIONE PER LA LOTTA ALLA SEU for their support and continuous commitment to our research.
Funding
No support/funding is present in this paper.
Author information
Authors and Affiliations
Consortia
Contributions
Dr. Ardissino performed data collection, analyzed the data, drafted the initial manuscript, and revised and approved the final version.
Dr. Tel, Testa, Paglialonga, Consolo, and Chidini designed the data collection instruments, performed data collection, revised the article, and approved the final version.
Dr. Longhi, Martelli, Picicco, Dodaro, and Daprai performed data collection, edited, revised, and approved the final version.
Dr. Colombo, Arghittu, Perrone, and Scalia Catenacci performed data collection, analyzed the data, revised the article, and approved the final version.
Dr. Consonni analyzed the data and performed the statistical analysis.
Corresponding author
Ethics declarations
The Ethics Committee of our hospital was informed about the study, which was conducted in accordance with our institution’s ethical regulations.
Conflicts of interest
The authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
Additional information
Communicated by Mario Bianchetti
Rights and permissions
About this article
Cite this article
Ardissino, G., Tel, F., Testa, S. et al. A simple prognostic index for Shigatoxin-related hemolytic uremic syndrome at onset: data from the ItalKid-HUS network. Eur J Pediatr 177, 1667–1674 (2018). https://doi.org/10.1007/s00431-018-3198-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-018-3198-7